Skip to main content
SpringerLink
Log in

Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?

  • Published:
Abdominal Imaging Aims and scope Submit manuscript

Abstract

Purpose

To assess the efficacy of contrast-enhanced ultrasonography (CEUS) with Sonovue in the evaluation of therapeutic response to radiofrequency ablation (RFA) of renal cell carcinoma (RCC).

Materials and methods

In a recent 3 years, 63 patients (mean age, 60 years; range 26–81 years) with 64 RCCs were treated by RFA. The lesions had a diameter between 1.8 and 9.8 cm (average diameter, 3.1 cm). The indications for RFA treatment included chronic renal insufficiency (n = 10), presence of solitary kidney (n =3), bilateral renal carcinoma (BRCC) (n =2), advanced age (n =12), significant medical comorbidity (n =29) or refusal of conventional therapy (n =7). Tumors were treated by laparoscopy-assisted (n =41), open surgical (n =18) or percutaneous US guidance (n =4). Follow-up CEUS and contrast-enhanced CT were performed 1 month after treatment to assess the necrotic area. Technical success was defined as elimination of areas that enhanced at imaging within the entire tumor.

Results

On the 1-month CEUS and CT imaging after RFA, 62 of 64 tumors (96.9%) were successfully ablated with one session, and residual tumors were found in two RCCs. One of the two tumors was subjected to additional RFA treatment. We could not obtain a complete ablation in the other tumor of a patient with solitary kidney. The diagnostic concordance between the CEUS and 1-month follow-up CT was 100%. Sixty-one patients survived in the follow-up phase which ranged from 2 to 34 months. One patient with solitary kidney died of systemic disease progression and one patient was lost to follow-up. Of the 61 tumors without residual on both CT and CEUS after RFA, four had suspicious findings of recurrence on follow-up CEUS, and two of them were confirmed by subsequent CT examination. With CT as the reference imaging procedure in the assessment of renal tumor ablation, the sensitivity, specificity, positive predictive value, and negative predictive value of CEUS for detecting recurrence during follow-up were 100%, 96.6%, 50%, and 100%.

Conclusion

Despite its limitation of false-positive value, CEUS is potentially effective in assessing the therapeutic response to RFA of RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Saskena M, Gervais D (2009) Percutaneous renal tumor ablation. Abdom Imaging 34:582–587

    Article  Google Scholar 

  2. Carraway WA, Raman JD, Cadeddu JA (2009) Current status of renal radiofrequency ablation. Curr Opin Urol 19:143–147

    Article  PubMed  Google Scholar 

  3. Mues AC, Landman J (2010) Image-guided percutaneous ablation of renal tumors: outcomes, technique, and application in urologic practice. Curr Urol Rep 11:8–14

    Article  PubMed  Google Scholar 

  4. Gervais DA, McGovern FJ, Arellano RS, et al. (2005) Radiofrequency ablation of renal cell carcinoma: part 1, indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185:64–71

    PubMed  Google Scholar 

  5. Rutherford EE, Cast JE, Breen DJ (2008) Immediate and long-term CT appearances following radiofrequency ablation of renal tumors. Clin Radiol 63:220–230

    Article  PubMed  CAS  Google Scholar 

  6. Boss A, Clasen S, Kuczyk M, et al. (2005) Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results. Rofo 177:1139–1145

    PubMed  CAS  Google Scholar 

  7. Zagoria RJ, Traver MA, Werle DM, et al. (2007) Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. AJR Am J Roentgenol 189:429–436

    Article  PubMed  Google Scholar 

  8. Salvaggio G, Campisi A, Lo Greco V, et al. (2010) Evaluation of post treatment response of hepatocellular carcinoma: comparison of ultrasonography with second-generation ultrasound contrast agent and multidetector CT. Abdom Imaging 35:447–453

    Article  PubMed  Google Scholar 

  9. Bartolotta TV, Taibbi A, Midiri M, et al. (2008) Hepatocellular cancer response to radiofrequency tumor ablation: contrast-enhanced ultrasound. Abdom Imaging 33:501–511

    Article  PubMed  Google Scholar 

  10. Kim CK, Choi D, Lim HK, et al. (2005) Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 56:66–73

    Article  PubMed  Google Scholar 

  11. Meloni MF, Bertolotto M, Alberzoni C, et al. (2008) Follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: contrast-enhanced sonography versus contrast-enhanced CT or MRI. AJR Am J Roentgenol 191:1233–1238

    Article  PubMed  Google Scholar 

  12. Goldberg SN, Grassi CJ, Cardella JF, et al. (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235:728–739

    Article  PubMed  Google Scholar 

  13. El-Galley R (2003) Surgical management of renal tumors. Radiol Clin North Am 41:1053–1065

    Article  PubMed  Google Scholar 

  14. Roos FC, Rübben H, Stief C, et al. (2010) Surgical treatment for renal cell carcinoma. Aktuelle Urol 41:252–256

    Article  PubMed  Google Scholar 

  15. Ljungberg B (2004) Nephron-sparing surgery—strategies for partial nephrectomy in renal cell carcinoma. Scand J Surg 93:126–131

    PubMed  CAS  Google Scholar 

  16. Thabet A, Kalva S, Gervais DA (2009) Percutaneous image-guided therapy of intra-abdominal malignancy: imaging evaluation of treatment response. Abdom Imaging 34:593–609

    Article  PubMed  Google Scholar 

  17. Setola SV, Catalano O, Sandomenico F, et al. (2007) Contrast-enhanced sonography of the kidney. Abdom Imaging 32:21–28

    Article  PubMed  CAS  Google Scholar 

  18. Goldberg SN, Gazelle GS, Compton CC, et al. (2000) Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic–pathologic correlation. Cancer 88:2452–2463

    Article  PubMed  CAS  Google Scholar 

  19. Nilsson A (2004) Contrast-enhanced ultrasound of the kidneys. Eur Radiol Suppl 14:104–109

    Article  Google Scholar 

  20. Cosgrove D (2006) Ultrasound contrast agents: an overview. Eur J Radiol 60:324–330

    Article  PubMed  Google Scholar 

  21. Lim HK, Choi D, Lee WJ, et al. (2001) Hepatocellular carcinoma treated with percutaneous radiofrequency ablation: evaluation with follow-up multiphase spiral CT. Radiology 221:447–454

    Article  PubMed  CAS  Google Scholar 

  22. Piscaglia F, Bolondi L, Italian Society for Ultrasound in Medicine, Biology (SIUMB) Study Group on Ultrasound Contrast Agents (2006) The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 32:1369–1375

    Article  PubMed  Google Scholar 

  23. Claudon M, Cosgrove D, Albrecht T, et al. (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)-update 2008. Ultraschall Med 29:28–44

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ultrasonic Room of Surgery, Drum Tower Hospital, Medical College of Nanjing University, Nanjing, 210008, China

    Wen-Tao Kong, Wei-Wei Zhang, Jun-Lan Qiu, Zhi-Min Jiang & Yi Shen

  2. Department of Urologic Surgery, Drum Tower Hospital, Medical College of Nanjing University, Nanjing, 210008, China

    Hong-Qian Guo, Xiao-Gong Li & Shi-Wei Zhang

  3. Department of Radiology, Drum Tower Hospital, Medical College of Nanjing University, Nanjing, 210008, China

    Min Tang

Authors
  1. Wen-Tao Kong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei-Wei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hong-Qian Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun-Lan Qiu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Min Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhi-Min Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yi Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xiao-Gong Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shi-Wei Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei-Wei Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kong, WT., Zhang, WW., Guo, HQ. et al. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?. Abdom Imaging 36, 342–347 (2011). https://doi.org/10.1007/s00261-010-9665-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-010-9665-x

Keywords

Search

Navigation